IP Library Granted Patent US 8,430,847
Granted Patent B2
US 8,430,847 · App. 12/817,049 · Granted Apr 30, 2013

Infusion pump system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,430,847
App. No.
12/817,049
Granted
Apr 30, 2013
Kind
B2
Abstract

An infusion pump system is described that increases patient comfort and convenience. The infusion pump system includes an infusion site interface that is releasably connected to an infusion pump body, and has no tubing associated between the infusion site interface and the pump body. The infusion pump body may include a carrier frame that may be adhered to the skin of a user.

Claims (14)

1. A medicine infusion pump system, comprising:

an infusion site interface structure that is adhesively attachable a skin surface, the infusion site interface structure comprising: a frame with a lower surface facing toward the skin surface, a soft cannula coupled to the frame for extension below the lower surface of the frame and configured for subcutaneously insertion through the skin surface to at least partially define a fluid path, and a septum arranged in the fluid path and having a major surface that extends generally parallel to the lower surface of the frame; and

an infusion pump device is releasably attachable to the frame of the infusion site interface structure so that a needle extending from the infusion pump device penetrates the septum of the infusion site interface, wherein when the infusion pump device is releasably attached to the frame of the infusion site interface structure, the infusion pump device dispenses a medicine through the fluid path from a medicine reservoir housed in the infusion pump device, through the penetrated septum of the infusion site interface structure, and through the soft cannula extending below the lower surface of the frame,

wherein the fluid path is configured to be intermittently broken and re-established when the infusion pump device which houses the medicine reservoir is temporarily disconnected from and reconnected with from infusion site structure while the infusion site interface structure is adhesively attached the skin surface.

2. The system of claim 1 , wherein the septum of the infusion site interface structure is arranged in the fluid path in a position above a generally upward facing surface of the frame which is opposite from the lower surface of the frame.

3. The system of claim 2 , wherein the infusion pump device covers over the generally upward facing surface of the frame of the infusion site interface when the infusion pump device is releasably attached to the frame of the infusion site interface structure.

4. The system of claim 3 , wherein the needle of the infusion pump device extends downwardly through an upper face of the septum such that the needle extends generally perpendicular to the skin surface when the needle penetrates the septum of the infusion site interface structure.

5. The system of claim 4 , wherein the frame of the infusion site interface structure comprises an inner ring hub that carries the septum and an outer wall that is spaced apart from the inner ring hub and surrounds the inner ring hub.

6. The system of claim 5 , wherein the soft cannula is rigidly attached to the inner ring hub of the frame of the infusion site interface structure.

7. The system of claim 6 , wherein when the infusion pump device is releasably attached to the frame of the infusion site interface structure, the needle of the infusion pump device is aligned with the inner ring hub of the frame of the infusion site interface structure.

8. The system of claim 1 , wherein when the infusion pump device is releasably attached to the frame of the infusion site interface structure, a mechanical coupling between the infusion pump device and the frame of the infusion site interface structure provides a direct connection such that the fluid path is free of tubing.

9. The system of claim 1 , wherein a mechanical coupling between the infusion pump device and the frame of the infusion site interface structure is secured by a detent fit.

10. The system of claim 1 , wherein a mechanical coupling between the infusion pump device and the frame of the infusion site interface structure is secured by an insert-and-rotate fit.

11. The system of claim 1 , further comprising a leak detection mechanism that provides a positive indication when the fluid path is compromised by a leak.

Assignments (20)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: ASANTE SOLUTIONS, INC.
To: ASANTE LLC
Reel/Frame 039871/0771 →
CHANGE OF NAME Recorded Aug 26, 2016
From: M2 GROUP HOLDINGS, INC.
To: ASANTE SOLUTIONS, INC.
Reel/Frame 039833/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: ASANTE LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 039827/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2016
From: MERNOE, MORTEN; CAUSEY, JAMES; WENGER, MITCHELL; ESTES, MARK C.
To: M2 MEDICAL A/S
Reel/Frame 039540/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2016
From: M2 MEDICAL A/S
To: M2 GROUP HOLDINGS, INC.
Reel/Frame 039540/0913 →